{
  "document_id": "HOUSE_OVERSIGHT_024021",
  "filename": "IMAGES-007-HOUSE_OVERSIGHT_024021.txt",
  "text": "NLV-III Investment Opportunity\nThe objective of NLV-III is to invest in a portfolio of healthcare technology companies that offer\n\nattractive risk-adjusted returns. The companies that comprise the portfolio will be selected and\nmanaged by a team of highly experienced senior partners who have developed and proven\ntheir investment process over many years and multiple funds. The investment strategy for\nNLYV-II] is similar to the strategies pursued in prior funds, in that it will have a core focus on\nbiopharmaceutical investments with a balance of investments across other healthcare\ntechnology sectors. Given the strength and stability of the team, the consistency and the depth\nof the track record, and the positive market forces and investment conditions that are expected\nto be in place during the life of the Fund, the Fund Managers believe NLV-III offers investors an\nopportunity for attractive returns.\n\n10 CONTROL NUMBER 257 - CONFIDENTIAL\n\nHOUSE_OVERSIGHT_024021",
  "metadata": {
    "original_filename": "IMAGES-007-HOUSE_OVERSIGHT_024021.txt",
    "source_dataset": "huggingface:tensonaut/EPSTEIN_FILES_20K",
    "character_count": 973,
    "word_count": 147,
    "line_count": 16,
    "import_date": "2025-11-19T21:47:45.543998",
    "prefix": "IMAGES-007"
  }
}